AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22689712 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 40
Study 22689712 — intervention group
Group type: EXPERIMENTAL
Intervention: Bepridil
Number of subjects: 40
Study 19816204 — intervention group
Group type: EXPERIMENTAL
Intervention: Low propofol (4 mg/kg/h)
Number of subjects: 34
Study 19816204 — intervention group
Group type: COMPARATOR
Intervention: High propofol (6 mg/kg/h)
Number of subjects: 34
Study 19816204 — intervention group
Group type: EXPERIMENTAL
Intervention: Both propofol concentrations
Number of subjects: 34
Study 19061063 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week structured exercise programme focusing on cardio respiratory endurance, strength and flexibility training
Number of subjects: 20
Study 16052090 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography for assessing facial lipoatrophy
Number of subjects: 0
Study 16052090 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12091806 — intervention group
Group type: EXPERIMENTAL
Intervention: HBOC-201 (Hemopure; Biopure Corporation, Cambridge, Mass)
Number of subjects: 98
Study 12091806 — intervention group
Group type: EXPERIMENTAL
Intervention: HBOC-201
Number of subjects: 98
Study 12091806 — intervention group
Group type: COMPARATOR
Intervention: Red blood cell units
Number of subjects: 98
Study 10501335 — intervention group
Group type: COMPARATOR
Intervention: Gray scale MCE alone
Number of subjects: 31
Study 10501335 — intervention group
Group type: COMPARATOR
Intervention: MCE combined with baseline 2D
Number of subjects: 31
Study 10501335 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtraction and color coding of triggered images
Number of subjects: 31
Study 10501335 — intervention group
Group type: COMPARATOR
Intervention: Gray scale MCE with baseline comparison
Number of subjects: 31
Study 10501335 — intervention group
Group type: COMPARATOR
Intervention: Gray scale MCE without baseline comparison
Number of subjects: 31
Study 10501335 — intervention group
Group type: EXPERIMENTAL
Intervention: Post processing of continuous images
Number of subjects: 31
Study 10501335 — intervention group
Group type: EXPERIMENTAL
Intervention: Colorized images
Number of subjects: 31
Study 8946597 — intervention group
Group type: EXPERIMENTAL
Intervention: SLE patients with reduced lymphocyte counts
Number of subjects: 29
Study 8946597 — intervention group
Group type: EXPERIMENTAL
Intervention: CD4+ T-PBL in SLE patients
Number of subjects: 29
Study 8946597 — intervention group
Group type: EXPERIMENTAL
Intervention: CD8+ T-PBL in SLE patients
Number of subjects: 29
Study 8946597 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient CD8+ T-PBL in SLE patients
Number of subjects: 29
Study 8946597 — intervention group
Group type: EXPERIMENTAL
Intervention: High anti-CL in SLE patients
Number of subjects: 29
Study 8946597 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss of naive and increase of transient CD8+ T-PBL in SLE patients
Number of subjects: 29
Study 1342326 — intervention group
Group type: EXPERIMENTAL
Intervention: Lottery ticket offer (intervention group)
Number of subjects: 954
Study 1342326 — intervention group
Group type: COMPARATOR
Intervention: No lottery ticket offer (control group)
Number of subjects: 954
Study 1342326 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall response rates
Number of subjects: 954
Study 1342326 — intervention group
Group type: EXPERIMENTAL
Intervention: Percent of urban dwellers
Number of subjects: 954
Study 1342326 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex
Number of subjects: 954
Study 12267105 — intervention group
Group type: EXPERIMENTAL
Intervention: IUDs with strings
Number of subjects: 300
Study 12267105 — intervention group
Group type: COMPARATOR
Intervention: IUDs without strings
Number of subjects: 300
Study 30614153 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (group P)
Number of subjects: 73
Study 30614153 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (group S)
Number of subjects: 73
Study 29216559 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol stove
Number of subjects: 324
Study 29216559 — intervention group
Group type: COMPARATOR
Intervention: Control (kerosene/firewood stove)
Number of subjects: 324
Study 26614017 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper Next (Dentsply Tulsa Dental Specialties)
Number of subjects: 210
Study 26614017 — intervention group
Group type: EXPERIMENTAL
Intervention: WaveOne (Dentsply Tulsa Dental Specialties)
Number of subjects: 210
Study 26614017 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciproc (VDW, Munich, Germany)
Number of subjects: 210
Study 23385306 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing consultations
Number of subjects: 287
Study 23385306 — intervention group
Group type: COMPARATOR
Intervention: Shared care
Number of subjects: 287
Study 23385306 — intervention group
Group type: COMPARATOR
Intervention: Rheumatologist consultations
Number of subjects: 287
Study 22595584 — intervention group
Group type: EXPERIMENTAL
Intervention: Near Needle Holder (NNH)
Number of subjects: 32
Study 22595584 — intervention group
Group type: COMPARATOR
Intervention: Cook Dieckmann manual IO needle
Number of subjects: 32
Study 20555369 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy milk (3 servings per day for 4 weeks)
Number of subjects: 31
Study 20555369 — intervention group
Group type: COMPARATOR
Intervention: Dairy milk (3 servings per day for 4 weeks)
Number of subjects: 31
Study 20555369 — intervention group
Group type: COMPARATOR
Intervention: Eccentric exercise bout
Number of subjects: 31
Study 18630532 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion on heat-sensitive acupoints
Number of subjects: 107
Study 18630532 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture, cupping, and TDP (Control)
Number of subjects: 107
Study 16187808 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive Voice Response (IVR) system for daily reports of cigarette use.
Number of subjects: 381
Study 16187808 — intervention group
Group type: COMPARATOR
Intervention: Timeline Follow-Back (TLFB) method for daily reports of cigarette use.
Number of subjects: 381
Study 12042274 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 5 inhibin B >400 pg/ml
Number of subjects: 54
Study 12042274 — intervention group
Group type: COMPARATOR
Intervention: Day 5 inhibin B <400 pg/ml
Number of subjects: 54
Study 10365802 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon therapy
Number of subjects: 26
Study 8746902 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary coronary angioplasty
Number of subjects: 301
Study 8746902 — intervention group
Group type: COMPARATOR
Intervention: Intravenous streptokinase therapy
Number of subjects: 301
Study 1791163 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc citrate (1%, w/w) and Triclosan (0.2%, w/w) dentifrice
Number of subjects: 102
Study 1791163 — intervention group
Group type: COMPARATOR
Intervention: Standard fluoride dentifrice
Number of subjects: 102
Study 6350616 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime 250 mg administered intramuscularly every 12 hours
Number of subjects: 60
Study 6350616 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime 500 mg administered intramuscularly every 12 hours
Number of subjects: 60
Study 6350616 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime 1000 mg administered intramuscularly every 12 hours
Number of subjects: 60
Study 30868641 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving therapy (PST)
Number of subjects: 73
Study 30868641 — intervention group
Group type: COMPARATOR
Intervention: Nutritional training (NT)
Number of subjects: 73
Study 30125034 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Disk Replacement (TDR)
Number of subjects: 96
Study 30125034 — intervention group
Group type: COMPARATOR
Intervention: Anterior Cervical Diskectomy and Fusion (ACDF)
Number of subjects: 96
Study 26847071 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 281
Study 26847071 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study 26847071 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline (excluding patients dying within one day of hospitalization)
Number of subjects: 281
Study 25600559 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncoated monofilament polypropylene mesh
Number of subjects: 48
Study 25600559 — intervention group
Group type: COMPARATOR
Intervention: Polypropylene‐polyurethane double surface mesh
Number of subjects: 48
Study 25600559 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study 22813476 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitions Clinic (primary care‐based care management program with a community health worker)
Number of subjects: 200
Study 22813476 — intervention group
Group type: COMPARATOR
Intervention: Expedited primary care
Number of subjects: 200
Study 22813476 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study 20004036 — intervention group
Group type: EXPERIMENTAL
Intervention: Known diabetes
Number of subjects: 1453
Study 20004036 — intervention group
Group type: EXPERIMENTAL
Intervention: New diabetes
Number of subjects: 1453
Study 20004036 — intervention group
Group type: EXPERIMENTAL
Intervention: Taking anti-hypertensive medication
Number of subjects: 1453
Study 20004036 — intervention group
Group type: COMPARATOR
Intervention: Impaired glucose tolerance (IGT) / Impaired fasting glucose (IFG)
Number of subjects: 1453
Study 20004036 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 1453
Study 17974536 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term retention (mean period 9.65 years)
Number of subjects: 64
Study 17974536 — intervention group
Group type: COMPARATOR
Intervention: Short-term retention (3-6 months)
Number of subjects: 64
Study 16316359 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral paricalcitol (mean dose 9.5 microg/week)
Number of subjects: 220
Study 16316359 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral paricalcitol
Number of subjects: 220
Study 16316359 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study 12115318 — intervention group
Group type: EXPERIMENTAL
Intervention: HA‐HAase test
Number of subjects: 70
Study 12115318 — intervention group
Group type: EXPERIMENTAL
Intervention: BTA‐Stat test
Number of subjects: 70
Study 12115318 — intervention group
Group type: EXPERIMENTAL
Intervention: HA‐HAase test in DOE workers
Number of subjects: 70
Study 12115318 — intervention group
Group type: EXPERIMENTAL
Intervention: BTA‐Stat test in DOE workers
Number of subjects: 70
Study 9689834 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2a and compression
Number of subjects: 4
Study 9689834 — intervention group
Group type: COMPARATOR
Intervention: Steroids (previous treatment)
Number of subjects: 4
Study 9689834 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group)
Number of subjects: 4
Study 8075780 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (HD) carbimazole 60 mg plus thyroxine 100-150 micrograms daily
Number of subjects: 70
Study 8075780 — intervention group
Group type: COMPARATOR
Intervention: Titration-dose (TD) carbimazole
Number of subjects: 70
Study 8075780 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (HD) and Titration-dose (TD) regimens
Number of subjects: 70
Study 2782339 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 8
Study 2782339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31685037 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-grain consumption (dietary advice to obtain at least half of cereal servings from whole-grain foods)
Number of subjects: 112
Study 31685037 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-grain consumption
Number of subjects: 112
Study 31685037 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual cereals)
Number of subjects: 112
Study 31544547 — intervention group
Group type: EXPERIMENTAL
Intervention: History of transcatheter arterial chemoembolization (TACE) treatment
Number of subjects: 58
Study 31544547 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor location
Number of subjects: 58
Study 31544547 — intervention group
Group type: COMPARATOR
Intervention: History of biliary manipulation
Number of subjects: 58
Study 29221779 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-g sodium oxybate (SXB)/nightly
Number of subjects: 155
Study 29221779 — intervention group
Group type: EXPERIMENTAL
Intervention: 200-600 mg/d modafinil
Number of subjects: 155
Study 29221779 — intervention group
Group type: EXPERIMENTAL
Intervention: SXB + modafinil
Number of subjects: 155
Study 29221779 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study 29221779 — intervention group
Group type: EXPERIMENTAL
Intervention: SXB
Number of subjects: 155
Study 29221779 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil alone
Number of subjects: 155
Study 26011257 — intervention group
Group type: EXPERIMENTAL
Intervention: FVOOT (functional virgin olive oil with thyme)
Number of subjects: 33
Study 26011257 — intervention group
Group type: EXPERIMENTAL
Intervention: FVOOT
Number of subjects: 33
Study 26011257 — intervention group
Group type: COMPARATOR
Intervention: VOO
Number of subjects: 33
Study 26011257 — intervention group
Group type: COMPARATOR
Intervention: FVOO
Number of subjects: 33
Study 23307617 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole grain rye bread (RB)
Number of subjects: 20
Study 23307617 — intervention group
Group type: COMPARATOR
Intervention: Refined wheat bread (WB)
Number of subjects: 20
Study 21316259 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravertebral block (PVB) group (n=20) - 15 ml of ropivacaine 0.2% every 6h combined with endovenous metamizol (1g)
Number of subjects: 40
Study 21316259 — intervention group
Group type: COMPARATOR
Intervention: Alternate NSAIDs group (AN) (n=20) - Paracetamol (1g) combined with metamizol (1g) every 6h
Number of subjects: 40
Study 20055118 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg b.i.d.
Number of subjects: 106
Study 20055118 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg q.d.
Number of subjects: 106
Study 16673060 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin beta
Number of subjects: 105
Study 16673060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 15513743 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held device (Tremorometer) for quantifying tremor
Number of subjects: 242
Study 11752357 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (81 mg every morning) before ibuprofen (400 mg every morning)
Number of subjects: 0
Study 11752357 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (81 mg every morning) before acetaminophen (1000 mg every morning)
Number of subjects: 0
Study 11752357 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (81 mg every morning) before rofecoxib (25 mg every morning)
Number of subjects: 0
Study 11752357 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated aspirin before ibuprofen (400 mg three times a day)
Number of subjects: 0
Study 11752357 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-coated aspirin before delayed-release diclofenac (75 mg twice daily)
Number of subjects: 0
Study 11752357 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (81 mg every morning) after ibuprofen (400 mg every morning)
Number of subjects: 0
Study 11752357 — intervention group
Group type: COMPARATOR
Intervention: Multiple daily doses of ibuprofen before aspirin
Number of subjects: 0
Study 9407270 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) for OCD, consisting of 12 weekly sessions.
Number of subjects: 52
Study 8288295 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-client transactional intervention
Number of subjects: 51
Study 8288295 — intervention group
Group type: COMPARATOR
Intervention: Control group (no transactional intervention)
Number of subjects: 51
Study 3814463 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen (500 mg)
Number of subjects: 5
Study 3814463 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac (200 mg)
Number of subjects: 5
Study 3814463 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (100 mg)
Number of subjects: 5
Study 3814463 — intervention group
Group type: COMPARATOR
Intervention: Piretanide (6 mg)
Number of subjects: 5
Study 3814463 — intervention group
Group type: COMPARATOR
Intervention: Naproxen (500 mg) with Hydrochlorothiazide (100 mg)
Number of subjects: 5
Study 3814463 — intervention group
Group type: COMPARATOR
Intervention: Naproxen (500 mg) with Piretanide (6 mg)
Number of subjects: 5
Study 3814463 — intervention group
Group type: COMPARATOR
Intervention: Sulindac (200 mg) with Hydrochlorothiazide (100 mg)
Number of subjects: 5
Study 3814463 — intervention group
Group type: COMPARATOR
Intervention: Sulindac (200 mg) with Piretanide (6 mg)
Number of subjects: 5
Study 29538682 — intervention group
Group type: EXPERIMENTAL
Intervention: Single vaccination with quadrivalent inactivated influenza vaccine (QIV)
Number of subjects: 132
Study 29538682 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster vaccination with quadrivalent inactivated influenza vaccine (QIV)
Number of subjects: 132
Study 29538682 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab therapy
Number of subjects: 132
Study 28018112 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin infusion
Number of subjects: 10
Study 28018112 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated capsaicin infusion
Number of subjects: 10
Study 28018112 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute capsaicin infusion
Number of subjects: 10
Study 24659021 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide (10 mg × 7 days) alone
Number of subjects: 0
Study 24659021 — intervention group
Group type: COMPARATOR
Intervention: Lenalidomide (10 mg × 7 days) with digoxin (0.5 mg on Day 5)
Number of subjects: 0
Study 24659021 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide (25 mg single dose) alone
Number of subjects: 0
Study 24659021 — intervention group
Group type: COMPARATOR
Intervention: Quinidine (300-600 mg twice-daily × 5 days) plus lenalidomide (on Day 4)
Number of subjects: 0
Study 24659021 — intervention group
Group type: EXPERIMENTAL
Intervention: Temsirolimus (25 mg single dose) alone
Number of subjects: 0
Study 24659021 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide plus temsirolimus (25 mg single dose)
Number of subjects: 0
Study 24659021 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Number of subjects: 0
Study 24659021 — intervention group
Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 0
Study 22572767 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 23 mg/day
Number of subjects: 0
Study 22572767 — intervention group
Group type: COMPARATOR
Intervention: Donepezil 10 mg/day
Number of subjects: 0
Study 22572767 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 23 mg/day with memantine
Number of subjects: 0
Study 22572767 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil 23 mg/day without memantine
Number of subjects: 0
Study 22572767 — intervention group
Group type: COMPARATOR
Intervention: Donepezil 10 mg/day with memantine
Number of subjects: 0
Study 22572767 — intervention group
Group type: COMPARATOR
Intervention: Donepezil 10 mg/day without memantine
Number of subjects: 0
Study 22572767 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 0
Study 19470086 — intervention group
Group type: EXPERIMENTAL
Intervention: Low protein/low glycaemic index diet
Number of subjects: 891
Study 19470086 — intervention group
Group type: EXPERIMENTAL
Intervention: Low protein/high glycaemic index diet
Number of subjects: 891
Study 19470086 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein/low glycaemic index diet
Number of subjects: 891
Study 19470086 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein/high glycaemic index diet
Number of subjects: 891
Study 19470086 — intervention group
Group type: COMPARATOR
Intervention: Control (national dietary guidelines)
Number of subjects: 891
Study 18425522 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (IVTA) injection
Number of subjects: 40
Study 18425522 — intervention group
Group type: COMPARATOR
Intervention: Arteriovenous (AV) sheathotomy
Number of subjects: 40
Study 16187470 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous morphine at 0.1 mg/kg
Number of subjects: 119
Study 14605954 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized flavonoid fractions (MFF) for 1 week
Number of subjects: 112
Study 10793494 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-assisted thoracoscopic lobectomy
Number of subjects: 20
Study 10793494 — intervention group
Group type: COMPARATOR
Intervention: Conventional lobectomy via open thoracotomy
Number of subjects: 20
Study 10793494 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Video-assisted thoracoscopic lobectomy and Conventional lobectomy)
Number of subjects: 20
Study 8610616 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 0
Study 1947593 — intervention group
Group type: COMPARATOR
Intervention: 0-hr nap
Number of subjects: 104
Study 1947593 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-hr nap
Number of subjects: 104
Study 1947593 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-hr nap
Number of subjects: 104
Study 1947593 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-hr nap
Number of subjects: 104
Study 6849725 — intervention group
Group type: EXPERIMENTAL
Intervention: Enflurane
Number of subjects: 75
Study 6849725 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 75
Study 6849725 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 75
Study 30456511 — intervention group
Group type: EXPERIMENTAL
Intervention: Captivator device
Number of subjects: 11
Study 30456511 — intervention group
Group type: COMPARATOR
Intervention: Duette device
Number of subjects: 11
Study 28688170 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthopedic reinforced gloves
Number of subjects: 193
Study 28688170 — intervention group
Group type: COMPARATOR
Intervention: Double standard gloves
Number of subjects: 193
Study 25837212 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle modification (LSM) with 80g pistachios daily for 3 months
Number of subjects: 60
Study 24014828 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT ON
Number of subjects: 608